UK regulator approves Lilly’s Alzheimer’s drug but ‘too expensive’ for wider use
- Posted on October 23, 2024
- By Financial Express
- 1 Views
UK regulator approves Lilly’s Alzheimer’s drug but ‘too expensive’ for wider use
Donanemab, given as an infusion every four weeks, has shown to slow down cognitive decline by 4-7 months in clinical studies.
